Lek S.A., Poland
| Държава: | Полша |
| Кратка информация: | Lek SA is a manufacturing company, a subsidiary of Sandoz. Lek SA Management Board consists of: Cristian Neculicioiu - Chairman of the Board, Paulina Pazio - Board member, Alan Knox - Board member, Rafal Gardener - a member of the Board. Office and office; Street. Podlipie 16, 95 - 010 Stryków. KRS: 0000061723, District Court for Lodz City Centre, XX Fac. KRS. NIP: 728-134-19-36. Share capital: 11 409 350 zł - paid in full. Sandoz - a company that wants to be first. Be the first to not only stand out from the competition, but also influence the shape of the entire market. Our goal is a qualitative change in the segment of generic drugs and increase their availability. • AVAILABILITY Sandoz has a vision of a healthier world in which everyone has access to the medications he needs - no matter who he is or where he lives. • Affordable We strive to ensure that more patients can benefit from affordable high quality medications. Our activities are aimed at mitigating the effects of diseases, and slowing rising costs of health care in the world. • INNOVATION We do not stop the production of cheaper copies of drugs. On the contrary, we are looking for innovative, advanced solutions that can exert real influence on the lives of patients. • HIGHEST HUMAN NOMINAL In the foreground are always people: patients, doctors, pharmacists, business partners or employees. Their needs are of utmost importance to us. We respect cultural differences, religious and social, with which we encounter in daily work. • HIGHEST QUALITY We have the necessary knowledge and experience that allow drugs offer patients the highest quality. We have modern production facilities on five continents and continues to invest in development. Renowned for its rigorous approach to quality and to introduce new standards in the generic drug industry. It all makes for a long time we enjoy the trust of our customers. • ALWAYS STEP BEFORE OTHER We attach great importance to this process development and manufacturing of generic medicines as soon as possible so that they can reach out to patients. Experience, work procedures, flexibility and global network enable us to respond quickly to market needs. |
| Сайт: | http://www.sandoz.pl/site/pl/o_nas/lek_sa/index.shtml |
